In particular, NCX1 is the main isoform expressed in nerve terminals of cognitively normal patients, while NCX2 and NCX3 seem to be modulated in the parietal cortex in a late AD stage, as NCX2 expression is increased in positive terminals, while NCX3 expression is reduced [104]. The gene discussed is SLC8A2; the disease is Alzheimer disease.